United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. (2014). Examining Concerns Regarding FDA's Proposed Changes to Generic Drug Labeling. ProQuest.
Chicago Style (17th ed.) CitationUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining Concerns Regarding FDA's Proposed Changes to Generic Drug Labeling. Bethesda, Md.: ProQuest, 2014.
MLA (9th ed.) CitationUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining Concerns Regarding FDA's Proposed Changes to Generic Drug Labeling. ProQuest, 2014.
Warning: These citations may not always be 100% accurate.